X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (111349) 111349
Book Review (22605) 22605
Publication (7889) 7889
Newspaper Article (3624) 3624
Newsletter (1257) 1257
Book Chapter (615) 615
Magazine Article (594) 594
Conference Proceeding (434) 434
Trade Publication Article (268) 268
Book / eBook (261) 261
Dissertation (105) 105
Web Resource (103) 103
Transcript (39) 39
Reference (21) 21
Report (16) 16
Data Set (15) 15
Paper (9) 9
Government Document (7) 7
Presentation (5) 5
Journal / eJournal (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (93105) 93105
humans (72999) 72999
male (44897) 44897
insulin (39276) 39276
female (38650) 38650
animals (34656) 34656
diabetes (29683) 29683
endocrinology & metabolism (25295) 25295
insulin resistance (23120) 23120
middle aged (22892) 22892
adult (22689) 22689
insulin - therapeutic use (22202) 22202
glucose (18154) 18154
hypoglycemic agents - therapeutic use (18065) 18065
insulin-resistance (16931) 16931
mice (14420) 14420
obesity (14377) 14377
aged (13870) 13870
rats (13654) 13654
type 2 diabetes (13408) 13408
diabetes mellitus, type 2 - drug therapy (13081) 13081
blood glucose - metabolism (12998) 12998
diabetes mellitus (12445) 12445
pharmacology & pharmacy (11954) 11954
risk factors (11069) 11069
abridged index medicus (11011) 11011
research (10811) 10811
metabolism (10192) 10192
insulin - blood (10031) 10031
analysis (9630) 9630
health aspects (8669) 8669
physiological aspects (8555) 8555
care and treatment (8381) 8381
adolescent (8109) 8109
rodents (8006) 8006
insulin - metabolism (7932) 7932
proteins (7543) 7543
metabolic syndrome (7434) 7434
blood glucose - analysis (7407) 7407
hyperglycemia (7407) 7407
diabetes mellitus, type 1 - drug therapy (7385) 7385
inflammation (7230) 7230
insulin - administration & dosage (7193) 7193
oxidative stress (6881) 6881
treatment outcome (6734) 6734
medicine (6665) 6665
mellitus (6544) 6544
diabetes mellitus - drug therapy (6291) 6291
diabetes mellitus, type 2 - blood (6259) 6259
expression (6024) 6024
child (6010) 6010
dextrose (5994) 5994
cell biology (5905) 5905
gene expression (5846) 5846
research article (5840) 5840
biochemistry & molecular biology (5797) 5797
medicine & public health (5678) 5678
internal medicine (5627) 5627
time factors (5621) 5621
article (5456) 5456
studies (5412) 5412
hypoglycemic agents - administration & dosage (5404) 5404
body mass index (5378) 5378
diabetes therapy (5335) 5335
medicine, general & internal (5331) 5331
multidisciplinary sciences (5247) 5247
medicine, research & experimental (5152) 5152
physiology (5140) 5140
therapy (5100) 5100
liver (5049) 5049
risk (4943) 4943
diet (4922) 4922
glycemic control (4858) 4858
hypoglycemia (4784) 4784
glucose metabolism (4718) 4718
mortality (4622) 4622
blood glucose - drug effects (4544) 4544
disease (4430) 4430
glucose - metabolism (4423) 4423
metformin (4415) 4415
body weight (4373) 4373
lipids (4362) 4362
hypertension (4361) 4361
type 1 diabetes (4351) 4351
mice, inbred c57bl (4337) 4337
signal transduction (4323) 4323
drug therapy (4306) 4306
glucose tolerance test (4274) 4274
insulin secretion (4187) 4187
hypoglycemic agents - pharmacology (4137) 4137
science (4132) 4132
insulin sensitivity (4111) 4111
nutrition & dietetics (4078) 4078
apoptosis (4039) 4039
medical research (4038) 4038
patients (3990) 3990
diabetes mellitus, type 2 - metabolism (3965) 3965
kinases (3869) 3869
cancer (3827) 3827
homeostasis (3824) 3824
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (145) 145
Online Resources - Online (57) 57
Collection Dvlpm't (Acquisitions) - Vendor file (26) 26
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
UofT at Mississauga - Stacks (6) 6
St. Michael's Hospital - Stacks (4) 4
Scarborough Hospital - Birchmount (3) 3
Thomas Fisher Rare Book - Rare Book (3) 3
UTL at Downsview - May be requested (3) 3
UofT at Scarborough - Stacks (3) 3
Baycrest Hospital - Stacks (2) 2
Gerstein Science - Circulation Desk (2) 2
Robarts - Stacks (2) 2
St. Michael's College (John M. Kelly) - 2nd Floor (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
University College (Laidlaw) - Stacks (2) 2
Baycrest Hospital - Resident/Client Library (1) 1
Engineering & Comp. Sci. - Material is damaged (1) 1
Engineering & Comp. Sci. - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Massey College (Robertson Davies) - Rare Book (1) 1
OISE - Theses (1) 1
Providence Healthcare - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
University Archives - Archives (1) 1
UofT at Mississauga - Not Returned (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (112152) 112152
German (1498) 1498
French (1152) 1152
Russian (674) 674
Japanese (607) 607
Chinese (354) 354
Spanish (310) 310
Polish (286) 286
Italian (177) 177
Czech (135) 135
Hungarian (96) 96
Portuguese (93) 93
Danish (71) 71
Swedish (68) 68
Dutch (62) 62
Finnish (48) 48
Bulgarian (41) 41
Norwegian (33) 33
Hebrew (32) 32
Serbian (27) 27
Turkish (20) 20
Ukrainian (19) 19
Croatian (18) 18
Korean (17) 17
Slovak (16) 16
Lithuanian (8) 8
Romanian (6) 6
Afrikaans (2) 2
Bosnian (1) 1
Greek (1) 1
Icelandic (1) 1
Indonesian (1) 1
Persian (1) 1
Urdu (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2014, ISBN 1934844632, xi, 228
Book
Web Resource
2007, Endocrinology and metabolism clinics of North America, Volume 36, suppl. 1., 52
Book
Diabetes technology & therapeutics, ISSN 1520-9156, 1999
Journal
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, pp. e77296 - e77296
In the present study, we investigated the therapeutic potential of a selective S1P1 receptor modulator, ponesimod, to protect and reverse autoimmune diabetes... 
Glucose-6-Phosphatase - genetics | Recurrence | Receptors, Lysosphingolipid - antagonists & inhibitors | Lymph Nodes - pathology | Spleen - immunology | Spleen - drug effects | Adoptive Transfer | CD3 Complex - genetics | T-Lymphocytes - drug effects | Receptors, Lysosphingolipid - genetics | Lymph Nodes - drug effects | B-Lymphocytes - pathology | Diabetes Mellitus, Type 1 - immunology | T-Lymphocytes - pathology | Spleen - pathology | Gene Expression | Drug Administration Schedule | Administration, Oral | Diabetes Mellitus, Type 1 - pathology | Self Tolerance | Diabetes Mellitus, Type 1 - genetics | Glucose-6-Phosphatase - immunology | Lymph Nodes - immunology | Diabetes Mellitus, Type 1 - drug therapy | Hypoglycemic Agents - pharmacology | Antibodies - pharmacology | B-Lymphocytes - drug effects | Receptors, Lysosphingolipid - immunology | Animals | B-Lymphocytes - immunology | Glucose-6-Phosphatase - antagonists & inhibitors | CD3 Complex - immunology | Lymphocyte Count | Mice, Inbred NOD | T-Lymphocytes - immunology | Mice | Thiazoles - pharmacology | Cell proliferation | Multiple sclerosis | Transplants & implants | Disease | Leukocyte migration | Transgenic | Lymphocytes T | Arthritis | Adoptive transfer | Lymph nodes | Restoration | Lymphocytes | Rodents | Peripheral blood | Remission | Catalysis | Pancreas | Spleen | Immunoglobulins | Medical treatment | Diabetes mellitus | CD3 antigen | Insulin | Immunological tolerance | Beta cells | Lymphocytes B | Diabetes | Islets of Langerhans | Autoimmune diseases | Glucose-6-phosphatase | Cell migration | Pharmaceuticals | Index Medicus
Journal Article
Diabetes Care, ISSN 0149-5992, 2009, Volume 32, Issue 5, pp. 762 - 768
0.0001). beta-Cell function measures returned to pretreatment values in both groups after a 4-week off-drug period. A1C and body weight rose to pretreatment... 
NON-INFERIORITY | GLYCEMIC CONTROL | SULFONYLUREA | GLUCAGON-LIKE PEPTIDE-1 | EXENDIN-4 | BASAL INSULIN | GLUCOSE | ENDOCRINOLOGY & METABOLISM | SECRETION | MELLITUS | TWICE-DAILY EXENATIDE | Metformin - therapeutic use | C-Peptide - blood | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Exenatide | Female | Insulin - analogs & derivatives | Insulin Secretion | Body Mass Index | Hypoglycemic Agents - therapeutic use | Insulin-Secreting Cells - physiology | Insulin, Long-Acting | Diabetes Mellitus, Type 2 - blood | Insulin - metabolism | Diabetes Mellitus, Type 2 - physiopathology | Insulin-Secreting Cells - drug effects | Insulin Glargine | Arginine - pharmacology | Venoms - therapeutic use | Kinetics | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Insulin - therapeutic use | Peptides - therapeutic use | Index Medicus | Original Research | Hemoglobin A | Insulin/analogs & derivatives/secretion/therapeutic use | Blood Glucose/metabolism | Type 2/blood/drug therapy/physiopathology | MEDICIN OCH HÄLSOVETENSKAP | Diabetes Mellitus | Insulin-Secreting Cells/drug effects/physiology | Venoms/therapeutic use | Metformin/therapeutic use | Glycosylated/metabolism | Peptides/therapeutic use | Arginine/pharmacology | Hypoglycemic Agents/therapeutic use | C-Peptide/blood | MEDICAL AND HEALTH SCIENCES
Journal Article
Journal Article
Current Alzheimer Research, ISSN 1567-2050, 04/2007, Volume 4, Issue 2, pp. 159 - 164
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 01/2011, Volume 121, Issue 1, pp. 308 - 317
Chronic infection with hepatitis C virus (HCV) is a major public health problem, with nearly 170 million infected individuals worldwide Current treatment for... 
MEDICINE, RESEARCH & EXPERIMENTAL | LIVER INFLAMMATION | GAMMA-INDUCIBLE PROTEIN-10 | VIRUS-INFECTION | DIPEPTIDYL-PEPTIDASE-IV | ANTIVIRAL THERAPY | INSULIN-RESISTANCE | IMMUNE-RESPONSES | CHRONIC HEPATITIS-C | LEVELS CORRELATE | PEGINTERFERON PLUS RIBAVIRIN | Chemokine CXCL10 - blood | Prognosis | Antiviral Agents - therapeutic use | Receptors, CXCR3 - blood | Humans | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Chemokine CXCL10 - antagonists & inhibitors | Dipeptidyl Peptidase 4 - blood | Hepatitis C, Chronic - virology | Hepatitis C, Chronic - therapy | Recombinant Proteins | Hepatitis C, Chronic - blood | Polyethylene Glycols - therapeutic use | T-Lymphocytes - virology | Treatment Failure | Hepatitis C, Chronic - immunology | Peptide Fragments - blood | Protein Array Analysis | T-Lymphocytes - immunology | Proteases | Physiological aspects | Research | Diagnosis | Hepatitis C | Drug therapy | Chemokines | Index Medicus | Abridged Index Medicus | Hepatitis C, Chronic/therapy | T-Lymphocytes/immunology | Polyethylene Glycols/therapeutic use | Dipeptidyl Peptidase 4/blood | Receptors, CXCR3/blood | Chemokine CXCL10/blood | T-Lymphocytes/virology | Hepatitis C, Chronic/blood | Interferon-alpha/therapeutic use | Chemokine CXCL10/antagonists & inhibitors | Life Sciences | Immunology | Antiviral Agents/therapeutic use | Hepatitis C, Chronic/immunology | Peptide Fragments/blood | Ribavirin/therapeutic use | Hepatitis C, Chronic/virology
Journal Article
2015, Frontiers in Diabetes, ISBN 331802337X, Volume 24
Web Resource
ANNALS OF INTERNAL MEDICINE, ISSN 0003-4819, 01/2011, Volume 154, Issue 2, pp. 103 - 103
Background: Insulin replacement in diabetes often requires prandial intervention to reach hemoglobin A(1c) (HbA(1c)) targets. Objective: To test whether... 
NPH INSULIN | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | ORAL-THERAPY | ADD-ON | GLUCOSE-LOWERING DRUGS | COMBINATION THERAPY | PARALLEL-GROUP | NAIVE PEOPLE | OPEN-LABEL | TO-TARGET TRIAL | Metformin - therapeutic use | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Body Weight - drug effects | Male | Thiazolidinediones - administration & dosage | Peptides - administration & dosage | Thiazolidinediones - therapeutic use | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Sensitivity and Specificity | Venoms - administration & dosage | Female | Insulin - analogs & derivatives | Metformin - administration & dosage | Drug Therapy, Combination | Hypoglycemic Agents - therapeutic use | Insulin, Long-Acting | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Insulin - administration & dosage | Diabetes Mellitus, Type 2 - blood | Insulin Glargine | Venoms - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - therapeutic use | Peptides - adverse effects | Peptides - therapeutic use | Type 2 diabetes | Glycosylated hemoglobin | Physiological aspects | Research | Diagnosis | Drug therapy | Injections | Side effects | Clinical trials | Diabetes | Hypoglycemia | Insulin | Weight | Index Medicus | Abridged Index Medicus
Journal Article
Regulatory Peptides, ISSN 0167-0115, 2008, Volume 149, Issue 1, pp. 79 - 83
The nose provides an effective way for delivering neuropeptides to the central nervous system, bypassing the blood-brain barrier and avoiding systemic side... 
Body weight regulation | Obesity | Neuropeptides | Intranasal administration | Cognition | Central nervous system | ALZHEIMER-DISEASE | PHYSIOLOGY | cognition | OBESE ZUCKER RATS | INSULIN-SECRETION | neuropeptides | CEREBROSPINAL-FLUID | BLOOD-PRESSURE | central nervous system | BODY-WEIGHT | intranasal administration | body weight regulation | CENTRAL-NERVOUS-SYSTEM | MELANIN-CONCENTRATING HORMONE | REDUCES FOOD-INTAKE | CENTRAL LEPTIN | obesity | Central Nervous System - metabolism | Humans | Adrenocorticotropic Hormone - pharmacology | Body Weight - drug effects | Melanocyte-Stimulating Hormones - pharmacology | Cognition Disorders - metabolism | Male | Peptide Fragments - pharmacology | Adrenocorticotropic Hormone - administration & dosage | Metabolic Diseases - therapy | Hypoglycemic Agents - administration & dosage | Neuropeptides - pharmacology | Receptors, Melanocortin - agonists | Female | Hypoglycemic Agents - therapeutic use | Satiety Response - drug effects | Insulin - pharmacology | Neuropeptides - administration & dosage | Adrenocorticotropic Hormone - therapeutic use | Melanocyte-Stimulating Hormones - administration & dosage | Peptide Fragments - administration & dosage | Nootropic Agents - therapeutic use | Insulin - administration & dosage | Administration, Intranasal | Hypoglycemic Agents - pharmacology | Neuropeptides - therapeutic use | Obesity - metabolism | Melanocyte-Stimulating Hormones - therapeutic use | Metabolic Diseases - metabolism | Signal Transduction - drug effects | Nootropic Agents - administration & dosage | Obesity - therapy | Peptide Fragments - therapeutic use | Cognition Disorders - therapy | Body Weight - physiology | Adipose Tissue - drug effects | Insulin - therapeutic use | Nootropic Agents - pharmacology | Index Medicus
Journal Article
Circulation: Heart Failure, ISSN 1941-3289, 01/2016, Volume 9, Issue 1
Background The prevalence of pre-diabetes mellitus and its consequences in patients with heart failure and reduced ejection fraction are not known. We... 
heart failure | Clinical trial | diabetes mellitus | prognosis | treatment outcome | clinical trial | CARDIAC & CARDIOVASCULAR SYSTEMS | PREDICTOR | TOLERANCE | HEMOGLOBIN A(1C) | HOSPITALIZATION | INHIBITION | A1C | INSULIN-RESISTANCE | GLUCOSE | DYSFUNCTION | OUTCOMES | Diabetes Mellitus - blood | Single-Blind Method | Prevalence | Prospective Studies | Ventricular Function, Left | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Heart Failure - physiopathology | Aminobutyrates - adverse effects | Male | Heart Failure - blood | Aminobutyrates - therapeutic use | Enalapril - therapeutic use | Enalapril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Time Factors | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Heart Failure - diagnosis | Diabetes Mellitus - diagnosis | Diabetes Mellitus - mortality | Prediabetic State - epidemiology | Heart Failure - mortality | Prediabetic State - blood | Risk Assessment | Comorbidity | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Biomarkers - blood | Heart Failure - drug therapy | Prediabetic State - mortality | Prediabetic State - diagnosis | Stroke Volume | Disease-Free Survival | Diabetes Mellitus - epidemiology | Tetrazoles - therapeutic use | Aged | Tetrazoles - adverse effects | Blood Glucose - metabolism | Angiotensin Receptor Antagonists - therapeutic use | Drug Combinations | Angiotensin Receptor Antagonists - adverse effects | Index Medicus | 10093 | 10150 | 10094 | Original | glucose | hospitalization | inhibition | Klinisk medicin | dysfunction | Clinical Medicine | a1c | insulin-resistance | hemoglobin a(1c) | Cardiovascular System & Cardiology | predictor | cardiovascular risk | tolerance
Journal Article